NCT04877678View on ClinicalTrials.gov

Effects of Second-generation Antihistamine Bepotastine on Cough Outcomes in Cough Patients With Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

September 1, 2022

Study Completion Date

October 31, 2022

Conditions
Allergic RhinitisCough
Interventions
DRUG

Bepotastine

10 mg Bepotastine, twice a day

DRUG

Placebo

Identical looking placebo, twice a day

Trial Locations (1)

Unknown

Asan medical center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER